ValuEngine cut shares of Molina Healthcare (NYSE:MOH) from a sell rating to a strong sell rating in a report released on Thursday morning, ValuEngine reports.

A number of other brokerages have also issued reports on MOH. Morgan Stanley dropped their price objective on shares of Molina Healthcare from $184.00 to $172.00 and set an overweight rating for the company in a report on Friday, August 23rd. BMO Capital Markets raised shares of Molina Healthcare from a market perform rating to an outperform rating and upped their target price for the company from $154.00 to $200.00 in a research report on Monday, June 3rd. Wells Fargo & Co raised shares of Molina Healthcare from a market perform rating to an outperform rating and set a $177.00 target price on the stock in a research report on Friday, May 31st. Deutsche Bank started coverage on shares of Molina Healthcare in a research report on Thursday. They issued a buy rating and a $145.00 target price on the stock. Finally, Stephens set a $150.00 target price on shares of Molina Healthcare and gave the company a hold rating in a research report on Wednesday, August 7th. Two investment analysts have rated the stock with a sell rating, five have assigned a hold rating, eight have issued a buy rating and one has given a strong buy rating to the company’s stock. The company currently has an average rating of Buy and an average price target of $160.83.

NYSE MOH traded up $0.99 on Thursday, hitting $114.93. 38,993 shares of the company’s stock traded hands, compared to its average volume of 497,109. The company has a current ratio of 1.73, a quick ratio of 1.73 and a debt-to-equity ratio of 0.85. Molina Healthcare has a 1-year low of $105.28 and a 1-year high of $159.00. The firm’s 50-day moving average price is $130.70 and its two-hundred day moving average price is $136.33. The firm has a market capitalization of $7.51 billion, a PE ratio of 10.38, a P/E/G ratio of 1.09 and a beta of 1.20.

Molina Healthcare (NYSE:MOH) last posted its earnings results on Tuesday, July 30th. The company reported $3.11 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.56 by $0.55. Molina Healthcare had a net margin of 4.48% and a return on equity of 51.49%. The firm had revenue of $4.19 billion during the quarter, compared to analysts’ expectations of $4.08 billion. During the same period in the previous year, the business posted $3.08 EPS. The business’s revenue was down 14.1% compared to the same quarter last year. On average, research analysts anticipate that Molina Healthcare will post 11.4 earnings per share for the current fiscal year.

In other Molina Healthcare news, Director Ronna Romney sold 375 shares of the stock in a transaction that occurred on Thursday, August 8th. The shares were sold at an average price of $131.63, for a total value of $49,361.25. The sale was disclosed in a document filed with the SEC, which is available through this link. Corporate insiders own 0.77% of the company’s stock.

Institutional investors and hedge funds have recently made changes to their positions in the company. Parallel Advisors LLC grew its position in shares of Molina Healthcare by 97.9% during the first quarter. Parallel Advisors LLC now owns 186 shares of the company’s stock worth $26,000 after acquiring an additional 92 shares during the last quarter. Advisors Preferred LLC purchased a new position in shares of Molina Healthcare during the second quarter worth approximately $37,000. Cornerstone Advisors Inc. grew its position in shares of Molina Healthcare by 3,577.8% during the first quarter. Cornerstone Advisors Inc. now owns 331 shares of the company’s stock worth $47,000 after acquiring an additional 322 shares during the last quarter. Stonebridge Capital Advisors LLC purchased a new position in shares of Molina Healthcare during the second quarter worth approximately $57,000. Finally, Financial Gravity Wealth Inc. grew its position in shares of Molina Healthcare by 35.0% during the second quarter. Financial Gravity Wealth Inc. now owns 501 shares of the company’s stock worth $72,000 after acquiring an additional 130 shares during the last quarter. Institutional investors and hedge funds own 96.99% of the company’s stock.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides Medicaid-related solutions to meet the health care needs of low-income families and individuals; and to assist state agencies in their administration of the Medicaid program in the United States. It operates through three segments: Health Plans, Molina Medicaid Solutions, and Other.

Further Reading: Sell-Side Analysts

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for Molina Healthcare (NYSE:MOH)

Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.